Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2025-12-24 @ 7:08 PM
NCT ID:
NCT02343757
Eligibility Criteria:
Inclusion Criteria:
* Patients with suspected AD, MCI and other cognitive impairment will be referred by their neurologist to have a clinical ordered FDG-PET/CT and clinically indicated AMYVID in addition,
* Patients equal to or greater than 21 years old,
* Signed informed consent by patient or legal guardian,
* Physically capable to cooperate.
Exclusion Criteria:
* Subjects who do not meet the above mentioned inclusion criteria,
* Subjects unwilling or unable to sign the informed consent form,
* Subjects with any significant psychiatric or neurologic disorder or disease other than dementia expected to interfere with the study,
* Subjects unable to undergo MR scanning due to exclusion via UHCMC MR restrictions (e.g. certain implanted metallic or electronic devices),
* History of adverse events related to a previous MR or PET/CT,
* Pregnant women,
* Minors.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT02343757
Study Brief:
Protocol Section:
NCT02343757